封面
市場調查報告書
商品編碼
1356589

局部給藥報告:2030 年趨勢、預測與競爭分析

Topical Drug Delivery Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

局部藥物傳輸趨勢與預測

預計到 2030 年,全球局部給藥市場將達到 3,966 億美元,2024 年至 2030 年年複合成長率為 8.5%。這個市場的主要促進因素是皮膚相關疾病發生率的增加、燒燙傷相關傷害發生率的增加以及糖尿病患病的上升。全球局部給藥市場的未來看起來充滿希望,居家醫療環境、醫院/診所和燒燙傷中心市場充滿機會。

局部給藥市場洞察

Lucintel 預測,半固態製劑由於其在輸送不同藥理化合物方面的彈性和易用性,將在預測期內實現最高成長。

由於對負擔得起且方便的局部藥物輸送服務的需求不斷成長,家庭護理機構將繼續成為最大的細分市場。

由於吸煙者數量的增加、對自我給藥藥物的高需求以及大型製藥公司的存在,預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要要素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些,由於材料或產品替代導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球局部給藥市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球局部給藥市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品的全球局部給藥市場
    • 半固態製劑
    • 液體配方
    • 固態製劑
    • 經皮吸收產品
  • 按給藥途徑給藥的全球局部給藥市場
    • 經皮經皮
    • 眼藥水藥物輸送
    • 直腸給藥
    • 陰道內給藥
    • 鼻腔給藥
  • 按最終用途行業分類的全球局部給藥市場
    • 家庭護理設置
    • 醫院和診所
    • 燒傷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球局部給藥市場(按地區)
  • 北美局部給藥市場
  • 歐洲局部給藥市場
  • 亞太地區局部給藥市場
  • 其他區域性局部給藥市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品的全球局部給藥市場成長機會
    • 按給藥途徑分類的全球局部給藥市場成長機會
    • 最終用途產業的全球局部給藥市場成長機會
    • 全球局部給藥市場區域成長機會
  • 全球局部給藥市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球局部給藥市場的產能擴張
    • 全球局部給藥市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M
簡介目錄

Topical Drug Delivery Trends and Forecast

The future of the global topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets. The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

A more than 150-page report is developed to help in your business decisions.

Topical Drug Delivery by Segment

The study includes a forecast for the global topical drug delivery by product, route of administration, end use industry, technology, and region.

Topical Drug Delivery Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products

Topical Drug Delivery Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

Topical Drug Delivery Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Others

Topical Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Topical Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies topical drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the topical drug delivery companies profiled in this report include-

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Topical Drug Delivery Market Insights

Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Home care settings will remain the largest segment due to increasing need for affordable and convenient topical drug delivery services in this setting.

North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Features of the Global Topical Drug Delivery Market

Market Size Estimates: Topical drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Topical drug delivery market size by product, route of administration, end use industry, and region. in terms of value ($B).

Regional Analysis: Topical drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, end use industries, and region.s for the topical drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the topical drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the topical drug delivery market size?

Answer: The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030.

Q.2. What is the growth forecast for topical drug delivery market?

Answer: The global topical drug delivery market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the topical drug delivery market?

Answer: The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

Q.4. What are the major segments for topical drug delivery market?

Answer: The future of the topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets.

Q.5. Who are the key topical drug delivery market companies?

Answer: Some of the key topical drug delivery companies are as follows:

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Q.6. Which topical drug delivery market segment will be the largest in future?

Answer: Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Q.7. In topical drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the topical drug delivery market by product (semi-solid formulations, liquid formulations, solid formulations, and transdermal products), route of administration (dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery), end use industry (home care settings, hospitals & clinics, burn centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Topical Drug Delivery Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Topical Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Topical Drug Delivery Market by Product
    • 3.3.1: Semi-Solid Formulations
    • 3.3.2: Liquid Formulations
    • 3.3.3: Solid Formulations
    • 3.3.4: Transdermal Products
  • 3.4: Global Topical Drug Delivery Market by Route of Administration
    • 3.4.1: Dermal Drug Delivery
    • 3.4.2: Ophthalmic Drug Delivery
    • 3.4.3: Rectal Drug Delivery
    • 3.4.4: Vaginal Drug Delivery
    • 3.4.5: Nasal Drug Delivery
  • 3.5: Global Topical Drug Delivery Market by End Use Industry
    • 3.5.1: Home Care Settings
    • 3.5.2: Hospitals & Clinics
    • 3.5.3: Burn Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Topical Drug Delivery Market by Region
  • 4.2: North American Topical Drug Delivery Market
    • 4.2.1: North American Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.2.2: North American Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.3: European Topical Drug Delivery Market
    • 4.3.1: European Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.3.2: European Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.4: APAC Topical Drug Delivery Market
    • 4.4.1: APAC Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.4.2: APAC Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.5: ROW Topical Drug Delivery Market
    • 4.5.1: ROW Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.5.2: ROW Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Topical Drug Delivery Market by Product
    • 6.1.2: Growth Opportunities for the Global Topical Drug Delivery Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Topical Drug Delivery Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Topical Drug Delivery Market Region
  • 6.2: Emerging Trends in the Global Topical Drug Delivery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Topical Drug Delivery Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Topical Drug Delivery Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Glenmark Pharmaceuticals
  • 7.2: Galderma
  • 7.3: Johnson & Johnson
  • 7.4: GlaxoSmithkline
  • 7.5: Bausch Health
  • 7.6: Hisamitsu Pharmaceuticals
  • 7.7: Cipla
  • 7.8: Bayer
  • 7.9: Viatris
  • 7.10: 3M